Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases, today announced that its management expects ...
Cartesian Therapeutics, Inc., a biotechnology company focused on mRNA cell therapies for autoimmune diseases, has announced its participation in several upcoming investor conferences in February ...
verdictfoodservice on MSN5d
Restaurant Brands International acquires Burger King China for $158mRBI has announced that one of its subsidiaries has acquired Burger King China from TFI Asia Holdings BV and Cartesian for ...
Cartesian Therapeutics (RNAC) announced the granting of inducement awards to five new employees. On February 3, 2025, the Company issued to ...
特殊目的收购公司Cartesian Growth Corporation II (NASDAQ: RENEU )市值1.53亿美元，该公司宣布第三次延长其完成初始业务合并的截止日期。新的截止日期延至2025年3月5日，公司正在寻求完成合并或收购交易。目前该股票交易价格接近52周高点12.00美元，表明市场对潜在交易前景持乐观态度。
Retail Asia on MSN4d
RBI acquires full ownership of Burger King China for $158mIt now seeks a new local partner as the controlling shareholder. Restaurant Brands International Inc. (RBI) has announced ...
The Fiber Broadband Association has published a new assessment looking at underground and aerial fiber deployment costs.
Source: Cartesian Therapeutics, Inc. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our ...
FREDERICK, Md., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback